SCHEMBL2263095

SCHEMBL2263095

Cc1cccc(F)c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29728159 1.00
Water SCHEMBL28752195 0.97 ACHE (0.52)
SCHEMBL62013 0.80
SCHEMBL8164803 0.80 ALDH1A1 (0.53)
SCHEMBL610147 0.80
SCHEMBL17563218 0.80 ACHE (0.44)
SCHEMBL126987 0.77 ALDH1A1 (0.50)
SCHEMBL6009043 0.77 CES2 (0.39)
SCHEMBL11261447 0.76 ACHE (0.38)
SCHEMBL3269484 0.75 ACHE (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692101-B1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES ALFA INSTR S R L (IT) 2022-01-12 EP claimed
EP-3692101-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES Alfa Instruments S.r.l. (IT) 2020-08-12 EP claimed
WO-2019068935-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES ALFA INSTRUMENTS S.R.L. (IT) 2019-04-11 WO claimed
US-7998623-B2 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2011-08-16 US claimed
US-20060078792-A1 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2006-04-13 US claimed
US-12612424-B2 HPK1 inhibitors and uses thereof REGOR PHARMACEUTICALS, INC. (US) 2026-04-28 US disclosed
US-20260008740-A1 BEXAROTENE DERIVATIVES AND THEIR USE IN TREATING CANCER DJ Therapeutics LLC (US) 2026-01-08 US disclosed
WO-2025201504-A1 KAT6 INHIBITORS BEIGENE (SUZHOU) CO., LTD. (CN) 2025-10-02 WO disclosed
US-20250304535-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-10-02 US disclosed
EP-3463362-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME LLC (US) 2025-09-03 EP disclosed
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
US-12338214-B2 Bexarotene derivatives and their use in treating cancer DJ Therapeutics LLC (US) 2025-06-24 US disclosed
EP-1237845-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-09-11 EP disclosed
CN-1347417-A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent UPJOHN CO (US) 2002-05-01 CN disclosed
WO-2001042189-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-06-14 WO disclosed
JP-2000281600-A PRODUCTION OF 4-BROMO-2-FLUOROBENZYL BROMIDE SEIMI CHEM CO LTD 2000-10-10 JP disclosed
CN-1046270-C Pyrimidine-thloalkyl and alkylether compounds PHARMACIA UPJOHN COMPANY (US) 1999-11-10 CN disclosed
CN-1134697-A Pyrimidine-sulfanyl and alkyl ether compounds UPJOHN CO (US) 1996-10-30 CN disclosed
US-5457235-A Halogenated diphenyldiacetylene liquid crystals DISPLAYTECH, INC. (US) 1995-10-10 US disclosed
US-4266082-A Preparation of 4-fluoro-3-phenoxy-toluene BAYER AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed